This Stock is a Buy and Has Growth Potential
It gets an “A” rating with triple-digit gains so far in 2020 and a suite of products that are rapidly gaining customers.
Read MorePosted by Louis Navellier, Investor Place | Jun 18, 2020
It gets an “A” rating with triple-digit gains so far in 2020 and a suite of products that are rapidly gaining customers.
Read MorePosted by Louis Navellier, Investor Place | Jun 3, 2020
It’s more than a great dividend payer– it’s a bona fide biopharmaceutical leader.
Read MorePosted by Louis Navellier, Investor Place | May 30, 2020
I’ve run my Portfolio Grader screens, and these are all A-rated winners that are perfect fits in anyone’s portfolio.
Read MorePosted by Louis Navellier, Investor Place | May 27, 2020
It’s downright cheap and a solid pick for any growth investor.
Read MorePosted by Louis Navellier, Investor Place | May 23, 2020
These top-rated companies should benefit when things start easing back to normal. Four of them hold “A” ratings in my Portfolio Grader, while two hold “B” ratings. All make smart buys here.
Read More